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Abstract
PadR-like transcriptional regulators form a structurally-related family of proteins that control the expression of genes
associated with detoxification, virulence and multi-drug resistance in bacteria. Only a few members of this family have been
studied by genetic, biochemical and biophysical methods, and their structure/function relationships are still largely
undefined. Here, we report the crystal structures of two PadR-like proteins from Bacillus cereus, which we named bcPadR1
and bcPadR2 (products of gene loci BC4206 and BCE3449 in strains ATCC 14579 and ATCC 10987, respectively). BC4206,
together with its neighboring gene BC4207, was previously shown to become significantly upregulated in presence of the
bacteriocin AS-48. DNA mobility shift assays reveal that bcPadR1 binds to a 250 bp intergenic region containing the
putative BC4206–BC4207 promoter sequence, while in-situ expression of bcPadR1 decreases bacteriocin tolerance, together
suggesting a role for bcPadR1 as repressor of BC4206–BC4207 transcription. The function of bcPadR2 (48% identical in
sequence to bcPadR1) is unknown, but the location of its gene just upstream from genes encoding a putative antibiotic ABC
efflux pump, suggests a role in regulating antibiotic resistance. The bcPadR proteins are structurally similar to LmrR, a PadR-
like transcription regulator in Lactococcus lactis that controls expression of a multidrug ABC transporter via a mechanism of
multidrug binding and induction. Together these proteins define a subfamily of conserved, relatively small PadR proteins
characterized by a single C-terminal helix for dimerization. Unlike LmrR, bcPadR1 and bcPadR2 lack a central pore for ligand
binding, making it unclear whether the transcriptional regulatory roles of bcPadR1 and bcPadR2 involve direct ligand
recognition and induction.
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Introduction
Members of the PadR-like protein family (accession no. Pfam
PF03551) form a large and widespread group of bacterial
transcription factors that regulate diverse processes including
multi-drug resistance, virulence and detoxification. They are
named after the phenolic acid decarboxylation repressor, which is
a transcription factor that represses genes associated with the
phenolic acid stress response in gram-positive bacteria such as
Bacillus subtilis, Pediococcus pentosaceus, and Lactobacillus plantarum
[1,2]. Besides the founding member, only a few of the PadR-like
proteins have been or are currently under investigation. These
include AphA, which activates virulence gene expression in Vibrio
cholerae [3], LmrR and LadR, which are repressors of genes
encoding a multi-drug resistance pump in Lactococcus lactis and
Listeria monocytogenesis, respectively [4,5], and Pex, a regulator of
circadian rhythms in Synechococcus elongates [6]. Crystal structures
have been reported of AphA, LmrR and Pex, confirming that
these proteins share a common fold consisting of two domains: a
highly conserved N-terminal winged helix-turn-helix (wHTH)
domain of approximately 80–90 amino acid residues, involved in
DNA-binding, and a variable C-terminal domain of one or more
a-helices, involved in dimerization [7–9]. PadR-like proteins are
related to members of the multiple antibiotic resistance regulator
(MarR) protein family, which have similar wHTH DNA-binding
domains but significantly larger and distinct C-terminal dimeriza-
tion domains [10]. The size of the C-terminal domain is also a
major discriminator among different PadR-like proteins, which
have been classified into two distinct subfamilies [4]. PadR-like
proteins of subfamily 1 (hereafter abbreviated as PadR-s1,
approximately 180 amino acids), which include AphA, PadR
and LadR, have relatively large C-terminal domains of about 80–
90 amino acids containing multiple a-helices, while subfamily 2
PadR-like proteins (PadR-s2, approximately 110 amino acids),
which includes LmrR, have significantly smaller C-terminal
domains of about 20–30 amino acids forming a single a-helix.
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Currently, the Protein Data Bank contains structures of only a
few PadR-s2 proteins. Among these proteins, LmrR is the only one
that has been studied both structurally and functionally: the
structures of the other proteins were solved by structural genomics
centers without a published record of their functional properties.
LmrR regulates the expression of LmrCD, a major multidrug
ABC efflux pump of L. lactis [11], via a mechanism involving
multidrug binding and induction [5,9]. Forming a negative
feedback loop, LmrR also regulates transcription of its own gene,
which is situated just upstream from the lmrCD genes, [12]. Crystal
structures of LmrR in complex with different ligands revealed that
LmrR contains an unusual multidrug binding site within a large
central hydrophobic pore at its dimer interface [9]. Multidrug
recognition is dominated by aromatic stacking interactions of the
flat heterocyclic cores of the ligands with opposing indole groups of
two dimer-related tryptophan residues (W96/W969), the prime
indicating the dimer-related subunit). Interestingly, the drug-
binding tryptophan residue in LmrR, which is located in the C-
terminal helix, is conserved in other PadR-s2 proteins, including
those with known structure. However, in these latter proteins the
equivalent tryptophans are buried in a completely closed dimer
interface, making it highly unlikely that they have a similar ligand-
binding role [9]. Unfortunately, assessment of the significance of
the structural differences between LmrR and the other PadR-s2
proteins is prohibited by the lack of complete functional data.
To investigate whether LmrR is an exceptional member of the
PadR-s2 family or whether its structural ligand-binding features
are preserved in other members, requires structure/function
analysis of LmrR homologs that function in multidrug or antibiotic
resistance. Such a homolog of LmrR was recently identified in
Bacillus cereus as the product of gene locus BC4206. Together with
its neighboring gene BC4207, which encodes a putative mem-
brane protein, BC4206 was shown to become highly upregulated if
B. cereus is treated with low concentrations of enterocin AS-48, a
broad-spectrum antimicrobial cyclic peptide produced by Entero-
coccus faecalis S-48 [13,14]. Here we report the crystal structure of
the BC4206 gene product from B. cereus strain ATCC 14579, a
subfamily-2 PadR-like protein which we named bcPadR1. In
addition, we report the crystal structure of a bcPadR1 homolog
from B. cereus strain ATCC 10987, the product of gene locus
BCE3449, which we named bcPadR2. This latter protein was
selected for structural characterization because its gene is
positioned in the vicinity of two genes encoding a putative
antibiotic ABC efflux pump (gene loci BCE3447 and BCE3446).
The proximity of these genes, similar as in the lmrR-lmrCD locus,
could indicate that bcPadR2 regulates the expression of the ABC
efflux pump, perhaps following a similar ligand binding and
induction mechanism as LmrR. Preliminary functional analysis,
combined with our structural analysis and comparison with related
proteins, reveal the roles of various conserved residues in the two
subfamily-2 PadR-like proteins from B. cereus. Based on our results,




The open reading frames encoding bcPadR1 and bcPadR2 were
amplified by PCR from the genomic DNA of Bacillus cereus strains
ATCC 14579 and ATCC 10987, respectively, and cloned in the
vector pNSC8048 [15]. Plasmid pNSC8048 carries the nisA
promoter, chloramphenicol selectable marker and a C-terminal
strep-tag (SRWSHPQFEK). The forward and reverse primers for
bcpadR1 (locus BC4206) were 59-CGACCATGGGGCACAGC-
CAAATGTTAAAAGGTGTA-39 and 59- GCTTCTA-
GACTCCCCCTGTAATAAGTTATT-39, respectively, while
forward and reverse primes for bcpadR2 (locus BCE3449) were
59-CGACCATGGAAAATTTAACTGAAATGCTGAAAG and
59-GCTTCTAGAGTTTGACTTCAAGACGTTAAT-39, re-
spectively. Those primers were designed to create NcoI/XbaI
restriction sites of the resulting PCR products (showed as bold and
underlined letters). The PCR fragments and pNSC8048 vector
were digested with NcoI and XbaI restriction enzymes and the
vector was dephosphorylated further with calf intestine alkaline
phosphatase (CIAP, Fermentas). Ligation was performed using T4
ligase (Roche) to yield pNSC-padR1 and pNSC-padR2. DNA
sequences of the plasmids were all verified by sequencing
(Macrogen, The Netherlands).
Expression and purification
To express bcPadR1 and bcPadR2, plasmids pNSC-padR1 and
pNSC-padR2 were transformed into L. lactis NZ9000 cells, which is
a derivative of strain MG1363 carrying the nisR/nisK genes crucial
for the induction and overexpression of the target protein under
the nisin inducible system. The transformed L. lactis NZ9000 cells
were grown in 100 ml of rich medium (M17, 0.5% glucose and
5 mg/mL chloramphenicol). After overnight growth at 30uC, the
culture was transferred into 2 L of fresh media and grown also at
30uC. Overexpression was induced with 5 ng/mL nisin when cells
were in the mid log phase (OD600 of 0.6–0.8) and growth was
continued for two hours. The cells were harvested by centrifuga-
tion (8000 rpm for 5 min at 4uC; JLA 10.500 rotor, Beckman),
washed with 50 mM Tris-HCl, pH 7.4, and re-centrifuged
(8000 rpm for 5 min at 4uC; 5810R rotor, Eppendorf). The
pellets were stored at 220uC until further use.
For purification, the cell pellets were resuspended in lysis buffer,
containing 100 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM
EDTA, supplemented with 10 mg/ml lysozyme and a tablet of a
Complete Protease Inhibitor cocktail (Roche). After 1 hour
incubation at 30uC, MgSO4 (10 mM) and DNAseI (10 mg/mL)
were added into the suspension and incubation was continued for
another 5 min. The cells were disrupted by sonication and
remaining cell debris was removed by centrifugation (12.000 rpm
for 10 min at 4uC; 5810R rotor, Eppendorf). BcPadR1 or bcPadR2
were purified from the supernatant using Streptactin Sepharose
column chromatography, according to the protocol provided by
the manufacturer (IBA Biotagnology GmbH). The protein-
containing elution fractions (in 100 mM Tris-HCl, pH 8.0,
150 mM NaCl, 1 mM EDTA, 2.5 mM desthiobiotin) were diluted
to 50 mM NaCl with buffer A (20 mM Tris-HCl, pH 8.0, 1 mM
EDTA and 1 mM dithithreitol) and then applied to a heparin
column (5 ml Heparin FastFlow, GE Healthcare), connected to an
A¨KTA Explorer FPLC system (GE Healthcare), to remove bound
DNA from the protein. The retained protein was eluted by
applying a linear gradient (2.5–100% in 15 column volumes) of
2 M NaCl in buffer A. The fractions containing bcPadR1 or
bcPadR2 were pooled and concentrated to ,8 mg/ml in buffer
containing 10 mM Tris-HCl, pH 8.0, 250 mM NaCl, 1 mM
EDTA and 1 mM DTT using an Amicon Ultra 3 kDa cut-off
concentrator (Millipore). The protein purity was confirmed by
silver-stained SDS PAGE.
Expression of bcPadR1 in B. cereus and determination of
antimicrobial activity of AS-48
Plasmid pNSC-padR1 was electroporated into B. cereus ATCC
14579 harboring the nisRK genes on plasmid pNZ9530 [16] and
expression was induced with 20 ng/mL of nisin. The antimicro-
bial activity of AS-48 was determined as the minimal inhibitory
Structures of PadR Regulators from B. cereus
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concentration (MIC) value against B. cereus following previous
practice [17]. Bacterial growth was followed in the presence of
various concentrations of AS-48 and monitored every 15 minutes
using a TECAN GENios Absorbance Reader (TECAN). Without
AS-48 addition, the final OD600 nm value (at the end of the
exponential phase) for the B. cereus culture was about 1.160.1. An
inhibition curve was made by plotting OD600 nm at the end of
incubation versus AS-48 concentration. The minimal inhibitory
concentration value was determined from the inhibition curve by
interpolation. The lowest concentration of AS-48 at which less
than 1% of the total increase in the OD600, measured in the
absence of AS-48, had occurred, was taken as the MIC value.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays (EMSAs) were carried out
essentially as described by Susanna et al [18]. The promoter
regions of B. cereus BC4206 and BC4029 genes were obtained by
PCR with oligos (for BC4206, 59-TTCAAGTGCCTTTGGTTC-
39 and 59-GATGCAACCTTCTAATAC-39; for BC4029 59-
TTTGCACGTTCTTCAAGC-39 and 59-CTTTCAGCATTT-
GACTTG-39) and the resulting fragments (250 bp and 347 bp for
BC4206 and BC4029, respectively) were end-labeled with [c-
33P]ATP using T4 polynucleotide kinase (Roche Nederland B.V.,
The Netherlands). Purified bcPadR1 protein and its DNA probe
were premixed on ice in binding buffer (20 mM Tris HCl
(pH 8.0), 5 mM MgCl2, 100 mM KCl, 0.5 mM dithiotreitol,
0.05 mg/ml poly(dI-dC), 0.05 mg/ml bovine serum albumin, and
8.7% glycerol) [18]. Reaction mixtures contained poly(dI-dC) that
is known to eliminate non-specific DNA binding. Samples were
incubated at 30uC, and were loaded on a 6% polyacrylamide gel
after 20 min incubation. Gels were run in 16 TBE buffer
(0.089 mM Tris, 0.089 mM boric acid, 0.022 mM EDTA) at
90 V for 60 minutes, dried in a vacuum dryer and autoradio-
graphed using phosphoscreens and a Cyclone PhosphorImager
(Packard Instruments, Meridien, CT).
Gel filtration. Analytical gel filtration was performed with a
Superdex 200 PC 3.2/30 gel filtration column (GE Healthcare),
mounted on a SMART-system (GE Healthcare). The running
buffer contained 20 mM Tris-HCl, pH 8.0, 200 mM NaCl,
1 mM EDTA and 1 mM dithithreitol. The injected protein
samples volumes were 20 ml. As molecular weight markers a
mixture of five proteins was used: aldolase 2158 kDa, bovine
serum albumin 267 kDa, ovalbumin 243 kDa, chymotrypsin
225 kDa, and ribonuclease 213.7 kDa.
Crystallization. Prior to crystallization trials, bcPadR1 was
subjected to Thermofluor-based stability optimization experiments
[19] that were performed on a thermal cycler (myIQ, Bio-Rad)
using Sypro-Orange dye (Invitrogen). The results revealed that
bcPadR1 was most stable in a buffer containing 20 mM MES
pH 6.0, 250 mM NaCl, 1 mM EDTA and 1 mM DTT.
Accordingly, both bcPadR1 and bcPadR2 were buffer exchanged
to the aforementioned buffer using a PD-10 desalting column (GE
Healthcare). The proteins were concentrated further to ,10 mg/
ml and either used immediately for crystallization or stored at
280uC.
Initial crystallization trials were set up as vapour-diffusion sitting
drops at 298 K using various commercially available screens [i.e.,
JCSG+ (Molecular Dimensions), Wizard Screen (Emerald Biosys-
tem), Structure Screen (Emerald Biosystem) and Cryo Screen
(Hampton Research)] and a Mosquito crystallization robot (TTP
LabTech) for drop dispensing. Droplets were composed of 0.2 ml
protein stock solution and 0.2 ml crystallization solution and were
equilibrated against 60 ml of the crystallization solution. Trigonal
pyramid crystals of bcPadR1 were obtained from JCSG+ Screen
condition no. 45, containing 0.17 M ammonium sulfate, 25.5%
(w/v) PEG 4000 and 15% (v/v) glycerol. These crystals were used
immediately for data collection without further optimization. For
bcPadR2, similar crystals grew from JCSG+ condition no. 60
(0.1 M imidazole, pH 8.0, and 10% (w/v) PEG 8000) which was
optimized manually using the hanging-drop vapour diffusion
method. The final crystallization solution contained 0.1 M
imidazole pH 8.0 and 9% (w/v) PEG 8000.
Data collection and structure determination. Prior to
diffraction data collection, a single bcPadR1 crystal with dimen-
sions of ,160 mm6160 mm6180 mm was transferred to a cryo-
protectant solution containing 0.17 M ammonium sulfate, 27%
(w/v) PEG 4000 and 20% (v/v) glycerol, and subsequently dipped
into liquid nitrogen. A similar procedure was applied to a bcPadR2
crystal (,100 mm6100 mm6160 mm) with 0.1 M imidazole,
pH 8.0, 10% (w/v) PEG 8000 and 20% (v/v) ethylene glycol as
cryo-protectant. Diffraction data up to 2.5 A˚ and 2.2 A˚ resolution
for bcPadR1 and bcPadR2, respectively, were collected at 100 K
using beam line ID14-2 at the ESRF, Grenoble, equipped with an
ADSC Quantum 4 detector (see Table 1 for data collection
statistics). The two data sets were indexed and integrated in space
group P4 with the program XDS [20], reindexed to space group
P422 and scaled and merged with the program Pointless and Scala
[21], respectively, from the CCP4 software package [22]. Data
collection statistics are shown in Table 1.
Table 1. Data collection and refinement.
bcPadR1 bcPadR2
Data collection
Wavelength (A˚) 0.9330 0.9330
Space group P41212 P43212
Unit cell dimensions (A˚) a = b = 73.5, c = 84.1 a = b = 43.9, c = 120.1
Resolution (A˚)* 44–2.5 (2.64–2.5) 44–2.2 (2.32–2.2)
Total observations 65429 49981
Unique reflections 8474 6500
,I/s.* 20.6 (2.9) 27.9 (3.3)
Completeness (%)* 100 (100) 99.7 (98.1)
Rmerge
* 0.074 (0.611) 0.042 (0.511)
Refinement




Non-H protein 826 825
Water 17 17
Ligand 28 (glycerol, sulfate) 0
Average B (A˚2) 58.3 67.8
RMSD
Bond lengths (A˚) 0.003 0.010
Bond angles (u) 0.702 1.010
Ramachandran plot
% most favoured 98.0 97.9
% disallowed 0.0 0.0
*Values in parentheses refer to the highest resolution shell.
1The R-factor is calculated for all measured reflections in the specified resolution
range, while the Rfree is calculated for reflections belonging to a random test set
not used in refinement (10% of the data).
doi:10.1371/journal.pone.0048015.t001
Structures of PadR Regulators from B. cereus
PLOS ONE | www.plosone.org 3 November 2012 | Volume 7 | Issue 11 | e48015
The structures of bcPadR1 and bcPadR2 were solved by
molecular replacement using the program Balbes [23] running
on the YSBL web server (http://www.ysbl.york.ac.uk/
YSBLPrograms/). The best solutions for the two proteins were
found using the structure of a transcriptional regulator from
Enterococcus faecalis V583 (PDB entry 3hhh) as a search model and
by changing the space groups to P41212 and P43212 for bcPadR1
and bcPadR2, respectively. The solutions were subjected to
automated model building using ARP/wARP [24] via the ARP/
wARP web service (http://cluster.embl-hamburg.de/ARPwARP/
remote-http.html), and completed by applying several cycles of
manual model building using COOT [25] and restrained-
refinement using Phenix.refine [26]. TLS (Translation/Libra-
tion/Screw) parameters [27] were included in the final rounds of
refinement, defining the HTH-domain and C-terminal helix as
two separate TLS groups. The final models of bcPadR1 and
bcPadR2 contain 103 residues (amino acids 3–105) and 99 residues
(amino acids 3–66 and 72–106), respectively. The geometry of the
models was validated by Molprobity [28].
Structure and sequence analysis. Structure and sequence
analysis was carried out using the following software: SuperPose
[29], for superimposition and calculation of root mean square
deviations (RMSDs); ESPript [30] and Jalview (http://www.
jalview.org) for preparation of sequence alignments; and Pymol
(Schro¨dinger, LLC) for the depiction of structures and preparation
of figures.
Accession numbers
Structure factors and the coordinates of the final models of
bcPadR1 and bcPadR2 have been deposited in the Protein Data
Bank (http://www.rcsb.org) with accession numbers 4ESB and
4ESF, respectively.
Results
Gene targets of bcPadR1 and bcPadR2
Genes associated with resistance mechanisms that are tran-
scriptionally controlled by PadR-like proteins are generally
encoded in the vicinity of the padR genes. Figure 1A shows the
chromosomal regions around the two B. cereus padR genes, in
comparison to the lmrR-lmrCD operon. The gene encoding
bcPadR1 (locus BC4206 in B. cereus ATCC 14579) is located
immediately downstream from BC4207, encoding a putative
membrane protein of unknown function. These genes are
predicted to share a common promoter, located immediately
upstream from BC4206. Transcriptome analysis revealed that
BC4206 and BC4207 are co-upregulated in response to enterocin
AS-48 [14], indicating that these genes indeed form a bicistronic
transcriptional unit. The same study also revealed that plasmid-
based overexpression of BC4207 increased the resistance of B.
cereus ATCC 14579 to AS-48, confirming the role of this gene in
bacteriocin resistance, although its mechanism of operation is
unknown. The BC4206-BC4207 transcriptional unit is conserved
among B. cereus and B. thuringiensis species, but not present in the
closely related B. anthracis [14]. To further examine the regulatory
role of BC4206, we also overexpressed this gene in B. cereus ATCC
14579. Overexpression results in an increased sensitivity against
AS-48 (MIC value of 1.0 mg/ml compared to a MIC value of
2.5 mg/ml for the wild-type strain, p-value,0.005, .6 cultures as
determined with Student’s t-test) suggesting that bcPadR1 acts as a
repressor of the BC4206-BC4207 transcriptional unit, when AS-
48 is not present in the medium. Electrophoretic mobility shift
assays further reveal that purified bcPadR1 specifically binds to the
intergenic region between BC4205 and the BC4206-BC4207
operon (Figure 1B and 1C). Incubation of the DNA probe with
0.5 mM bcPadR1 results in shifted bands, while higher bcPadR1
concentration results in stronger, but more diffused binding
(Figure 1C). This might indicate the binding of two or more
bcPadR1 dimers to the probe. The DNA probe used in these
experiments contains the upstream regulatory region of BC4205
that codes for a putative spore photoproduct lyase. The expression
of BC4205 is not altered in response to AS-48 addition [14], so its
expression is likely to be unrelated to the AS-48 induced
expression of BC4206-BC4207 operon. In vitro DNA binding of
bcPadR1 was not affected by the addition of AS-48 suggesting an
indirect sensing of AS-48 in the medium, although we cannot
exclude the possibility that slightly altered in vitro conditions (e.g.
different binding buffer) are needed to observe any effect of AS-48
addition on DNA binding.
The gene encoding bcPadR2 (locus BCE3449 in B. cereus ATCC
10987) lies downstream from two genes, BCE3447 and BCE3446,
which encode a putative ABC-efflux pump. The product of
BCE3447 forms the ATPase subunit of the transporter, while the
product of BCE3446 forms the membrane permease. Interesting-
ly, the amino acid sequence of the BCE3447-BCE3346 encoded
pump is similar to that of the daunorubicin/doxorubicin resistance
ABC transporter DrrAB from Streptomyces peucetius (overall
sequence identity of 32%) [31,32]. The sequence identity of the
BCE3447-BCE3346 encoded pump with LmrCD is 27%, but
LmrCD is about twice as large as BCE3447-BCE3446 and
DrrAB. DNA analysis indicates that the BCE3449 and BCE3447-
BCE3346 genes do not share a common promoter, and are
separated by another gene, BCE3448, which encodes a soluble
protein of unknown function. The structure of the BCE3448-
encoded protein has been solved by a structural genomics
consortium (PDB entry 2O3L) and shows a left-handed superhelix
fold containing 5 a-helices. Genomic analysis reveals that the
BCE3449-BCE3448-BCE3447-BCE3446 gene organization is
conserved in various Bacillus species, but without functional
expression data we cannot confirm that these genes form an
operon or are coregulated.
Sequence analysis
BcPadR1 and bcPadR2 contain 105 and 106 amino acid
residues, respectively, and have all the characteristics of the PadR-
s2 protein family. Figure 2 shows a multiple sequence alignment of
the two proteins with other PadR-s2 proteins of which structures
are currently deposited in the PDB, including LmrR. Pair-wise
sequence identities range from 20% (bcPadR2 compared with a
transcriptional regulator from Clostridium thermocellum, PDB entry
1XMA) to 61% (bcPadR2 compared with a transcriptional
regulator from Enterococcus faecalis V583, PDB entry 3HHH).
BcPadR1 and bcPadR2 share a sequence identity of 45%, and are
26% and 30% identical in sequence to LmrR, respectively. Using
an alignment-derived profile hidden Markov model, all homologs
of bcPadR1 and bcPadR2 currently deposited in the Uniprot
database were identified (.2150 sequences) and used to derive
conserved sequence motifs. The highly conserved residues of the
PadR-s2 proteins are mainly located in the wHTH domain and
cluster in three regions, (i) at the N-terminus of helix a2 [motif
YGYE(I/L)], (ii) in helix a3 [motif EGT(L/I)YPxLxRLE] and (iii)
in the region encompassing strand b2 of the wing and the N-
terminus of helix a2 [motif G(P/R)RKYYx(L/I)TxxG]. The
identified sequence motifs partly overlap with the consensus
sequence previously derived for all PadR-like proteins [4]. In
addition to the above mentioned conserved sequence motifs, other
highly conserved residues are found in more isolated positions at
the N-terminus, helix a1 and the C-terminal helix of the subfamily
Structures of PadR Regulators from B. cereus
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Figure 1. Genomic neighborhood of the bcPadR1 and bcPadr2 encoding genes and analysis of promoter binding. (A) Organization of the
BC4206(bcPadR1)-BC4207 operon of B. cereus ATCC 14579, the putative BCE3449(bcPadR2)-BCE3448-BCE3447-BCE3446 regulon of B. cereus ATCC 10987
and the lmrR-lmrCD regulon of L. lactis. The relative scale of the genes and intergenic regions is proportional to nucleotide length. Boxes indicate the
operon/regulon boundaries. The PadR-encoding genes are colored in yellow, while their (putative) target genes, encoding resistance-associated
membrane proteins, are in green. (B) The sequence of the intergenic region between BC4205 and BC4206 that is used for the EMSA experiments.
Putative -35 and -10 promoter sequences of BC4206 are underlined, the start codons of BC4205 and BC4206 are highlighted in bold, and the amino acids
of the coded proteins are indicated above the DNA sequence. The putative binding site of bcPadR1 (homologous to the canonical ATGT/ACAT inverted
sequence motif) is highlighted in blue. (C) EMSA experiments with bcPadR1. DNA fragments encompassing the promoter regions of BC4206 (lanes 1–10)
and BC4029 (lanes 11–13, negative control) were prepared by PCR and end labeled with 33P. DNA binding was assayed as described in the Materials and
Methods. Lanes 1, 10 and 11 contain the free DNA probe. Samples run on lanes 2 and 12 contain 0.5 mM; lane 3 1 mM; lanes 4–9 and 13 2 mM of purified
bcPadR1 protein. Lanes 5 to 9 contains samples including increasing concentrations of AS-48 from 0.5 pM to 0.69 mM.
doi:10.1371/journal.pone.0048015.g001
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2 PadR-like proteins, including the central tryptophan residue in
the C-terminal helix which has a central role in multidrug-binding
in LmrR.
Structure determination
To allow easy production of pure protein for crystallization,
bcPadR1 and bcPadR2 were expressed with a C-terminal
streptavidin-tag (SRWSHPQFEK) using an L. lactis nisin-overex-
pression system. Protein purification was carried out in two steps
using Strep-Tactin and DNA affinity chromatography. Gel
filtration experiments revealed that the recombinant bcPadR1
and bcPadR2 proteins have an apparent molecular weight of ,43
kDa, similar as observed previously for LmrR and consistent with
the presence of elongated dimers in solution (the calculated
molecular weight of monomeric strep-tagged bcPadR1 and
bcPadR2 is 13.3 kDa and 13.7 kDa, respectively)
BcPadR1 was crystallized in space group P41212, with one
protein molecule per asymmetric unit and a solvent content of
71%. Similarly, bcPadR2 was crystallized in space group P43212,
with one protein molecule per asymmetric unit and a solvent
content of 42%. The bcPadR structures were determined by
molecular replacement using the structure of the PadR-like protein
from E. faecalis V583 as a search model. Model building and
refinement were somewhat hampered by relatively high atomic
displacement parameters (B-factors), indicative of some global
disorder or flexibility of the proteins, even though the overall fit to
the electron density is well defined. The final refined structures of
bcPadR1 and bcPadR2 have an R-factor/Rfree of 20.2/22.6% at
2.5 A˚ resolution and 22.3/27.7% at 2.2 A˚ resolution, respectively,
with good geometry (see Table 1 for details of the refinement
statistics). The two structures are highly similar with a Ca-
backbone root mean square deviation (RMSD) of 1.45 A˚ (for 96
common residues). The N-termini (residues 1–2 in both bcPadR
proteins) and the C-terminal strep-tags (residues 106–115 in
bcPadR1 and residues 108–116 in bcPadR2) were not included in
the models due to weak or absent electron density. In addition,
residues 67–71 in the b-wing of bcPadR2 were found to be
disordered and therefore left out from the model.
Overall structures of bcPadR1 and bcPadR2
In the crystals, bcPadR1 and bcPadR2 form similar dimers, with
a dimeric 2-fold axis that coincides with a crystallographic 2-fold
Figure 2. Multiple sequence alignment of bcPadR1, bcPadR2, and other members of the PadR-s2 subfamily. Only sequences for which
structures are available in the PDB are shown in the alignment. The PadR-s2 proteins with unpublished structures are addressed by their PDB entry
names: 1XMA, a putative transcriptional regulator from Clostridium thermocellum; 3HHH, a putative transcriptional regulator from Enterococcus
faecalis V583; 3L7W, uncharacterized protein SMU.1704 from Streptococcus mutans UA159; 3RI2, a putative transcriptional regulator from Eggerthella
lenta DSM 2243. Residues that participate in dimerization (for bcPadR1, bcPadR2, and LmrR) and/or have a role in drug binding (only for LmrR) are
indicated by small spheres below the sequences. The consensus sequence is derived from a multiple sequence alignment of 2156 PadR-s2 proteins
using as criteria that the conserved residue(s) should be present in at least 50% of the sequences.
doi:10.1371/journal.pone.0048015.g002
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axis. The approximate dimensions of the dimers are
80 A˚634 A˚630 A˚ (Figure 3A). The bcPadR1 and bcPadR2
subunits contain a typical wHTH DNA-binding domain, consist-
ing of helices a1, a2, the DNA recognition helix a3 and strands b1
and b2 (together forming the wing), and a dimerization domain,
including the C-terminal helix a4. Helix a4 forms a protruding
arm which in the dimer interacts with helices a49 and a19 of the
dimer-mate. Dimerization of bcPadR1 and bcPadR2 buries
approximately 1740 A˚2 solvent-accesible surface area per subunit
which is related to ,30% of the total surface area. The dimeric
interface involves mainly van der Waals contacts between
hydrophobic residues, most of which are conserved between the
two bcPadR proteins (see Figure 2). In addition a few hydrogen
bonds are observed at the dimer interface, but these are not
conserved.
BcPadR1 and bcPadR2 show a closed dimeric interface
Although similar in overall fold, it is evident that the two
bcPadR structures do not show the same dimeric interface as
LmrR (Figures 3 and 4). Unlike LmrR, but like the other PadR-s2
proteins with known structure, the bcPadR1 and bcPadR2 dimers
have a completely closed dimer interface. The differences at the
dimer interface are associated with changes in the relative
orientation of helices a1 and a4 with respect to the core of the
wHTH domain (Figure 4B). In addition, helix a4 in bcPadR1 and
bcPadR2 shows significant bending towards the dimeric centre,
whereas the equivalent helix in LmrR is almost perfectly straight
(Figure 4C). As a consequence, helices a4 and a49 in the bcPadR
dimers can approach each other closely at the dimer interface,
allowing a coiled-coil interaction mode. In LmrR the C-terminal
helices do not make any mutual contacts, but, instead, interact
strongly with helices a1 and a2 of the dimer mate. Intriguingly,
despite these significant differences in dimeric organization, the
residues in bcPadR proteins and LmrR that form the inter-subunit
interactions are located at similar positions in the structures
(Figure 2). It is unclear how the differences in amino acid sequence
at these regions affect the conformation of the polypeptides in the
dimer. In particular, the highly conserved tryptophan residues in
the C-terminal helices of the bcPadR dimers (Trp91/Trp919 and
Trp93/Trp939 in bcPadR1 and bcPadR2, respectively), which are
the equivalent of Trp96/Trp969 in LmrR, are completely buried
in the dimer interface. The closed dimer conformation and
inaccessibility of the conserved tryptophan residues of the bcPadR
proteins are incompatible with a drug-binding mechanism as
observed in LmrR.
Structural similarity with non-PadR-like transcription
factors
A structural similarity search against available structures in the
Protein Data Bank (PDB) using the DALI server [33] reveals that
bcPadR1 and bcPadR2 are not only similar to other PadR-like
proteins, but also to various non-PadR-like transcription factors
including members of the MarR family, SmtB/ArsR family and
the MecI/BlaI family (Table 2). These proteins all contain
Figure 3. Ribbon representations of the bcPadR dimers and selected structural homolog. (A) bcPadR1, (B) bcPadR2, (C) LmrR (PDB code
3F8B), and (D) RTP, a replication terminator protein from Bacillus subtilis (PDB code 1F4K). For each dimer, one of the subunits is shown in a rainbow
color gradient from the N-terminus (blue) to the C-terminus (red), whereas the other subunit is colored grey. Helices involved in dimerization are
indicated. Residues Trp91 of bcPadR1, Trp93 of bcPadR2, and Trp96 of LmrR are drawn in stick representation.
doi:10.1371/journal.pone.0048015.g003
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wHTH-domains for DNA binding and form functional dimers.
The similarities of the non-PadR-like structural homologs of
bcPadR1 and bcPadR2 are mainly limited to the wHTH domains,
which can be superimposed to those of bcPadR1 and bcPadR2 with
RMSDs (for Ca-backbone superpositions) of 1.1–1.9 A˚
(Figure 4A). In contrast, the dimerization topologies of the non-
PadR-like structural homologs of bcPadR1 and bcPadR2 are highly
diverse, often including additional helices at the N- and C-terminal
regions. One notable exception is the transcription factor RTP
(replication terminator protein) from Bacillus subtilis, which plays a
crucial role in the coordinated termination of DNA replication
[34]. Despite the absence of significant sequence homology,
bcPadR1 and bcPadR2 show a highly similar overall topology and
dimeric organization as RTP, including the presence of a single C-
terminal helix for dimerization (Figure 3). The striking similarities
of the bcPadR and RTP structures strongly suggest that these
proteins use a common mode of DNA binding.
Putative DNA-binding interactions
To understand how bcPadR1 and bcPadR2 may bind to DNA,
the bcPadR structures were superimposed to structures of close
homologs in complex with DNA (Figure 5). At present no structure
is available of a PadR-like protein bound to its cognate DNA.
However, DNA-bound structures are available for two of the non-
PadR-like close homologs identified by the DALI search, i.e., the
replication terminator protein RTP (PDB entry 1F4K) and the
transcriptional repressor BlaI (PDB entry 1XSD) [34,35]. RTP
and BlaI exploit common principles to fulfill their role as DNA-
binding regulatory proteins, which most probably are also used by
the bcPadR proteins. The operator sequences of RTP and BlaI
Figure 4. Structural comparison between bcPadR1, bcPadR2 and LmrR. (A) Superpositions of the wHTH domains of bcPadR1 (light-green),
bcPadR2 (red), LmrR (blue), and the following homologs: MexR (green), SmtB (magenta), BlaI (cyan), RTP (orange), and Pex (gray) with the secondary
structure elements indicated and labeled. (B) Superposition of the single bcPadR1, bcPadR2 and LmR subunits. (D) Superposition of the bcPadR1,
bcPadR2 and LmR dimers.
doi:10.1371/journal.pone.0048015.g004
Table 2. DALI-identified structural homologs of bcPadR1 and bcPadR2.*
bcPadR1/bcPadR2
PDB-ID Z-score RMSD (A˚) Ca aligned Nr. res % id. Protein name Protein family Ref.
3HHH 16.1/17.7 1.6/1.7 101/101 103/103 42/61 n.k. PadR-s2 u.
3L7W 14.2/13.6 2.0/2.7 99/100 106/106 27/27 n.k. PadR-s2 u.
3RI2 14.0/14.0 2.5/1.6 99/100 112/112 30/26 n.k. PadR-s2 u.
1XMA 13.9/14.8 2.6/1.5 97/98 103/101 22/20 n.k. PadR-s2 u.
1LNW 12.8/12.0 2.7/3.0 93/88 141/141 13/16 MexR MarR [40]
3F8B 12.5/11.7 3.1/2.7 100/98 105/101 23/30 LmrR PadR-s2 [9]
1YG2 11.0/10.6 3.2/2.8 83/82 169/169 22/24 AphA PadR-s1 [8]
1F4K 10.6/11.0 3.1/2.5 98/98 115/115 12/15 RTP RTP [34]
1SMT 10.1/9.5 2.6/2.9 78/77 98/101 14/19 SmtB SmtB/ArsR [41]
1SD6 9.7/9.6 3.3/3.1 84/84 119/119 15/19 BlaI MecI/BlaI [35]
2E1N 9.3/9.1 3.5/3.1 90/89 112/112 21/25 Pex PadR-s1 [7]
Abbreviations: PadR-s1, PadR-like subfamily-1; PadR-s2, PadR-like subfamily-2, n.k., not known; u, unpublished.
*The DALI-search was performed using a single subunit of each bcPadR dimer.
doi:10.1371/journal.pone.0048015.t002
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contain specific inverted repeat motifs and the proteins bind such
that their dimeric dyads are aligned with the inverted repeat dyads
of the DNA operators. In this way, the recognition helices (a3) of
the dimer-related wHTH domains can insert into two successive
major grooves of the DNA, while the b-wings lie across the
phosphate backbone, within the vicinity of adjacent minor groove
clefts. DNA binding is stabilized by electrostatic interactions
between the highly positively charged surface of the DNA binding
site and the negatively charged DNA backbone. Additional
DNA:protein interactions comprise various non-bonding contacts,
including hydrophobic interactions, and a few hydrogen bond
interactions. Residues in the a3-helix are responsible for specific
DNA binding and recognition of the operator DNA sequence, by
penetrating into the major groove and forming hydrogen bonds
with bases of the nucleotides.
The bcPadR1 dimer can be superimposed to the DNA-bound
complexes of RTP and BlaI with RMSD values of 3.5 A˚ (for 176
common Ca atoms divided equally between both subunits) and
4.1 A˚ (for 153 common Ca atoms), respectively. Likewise, the
bcPadR2 dimer can be fitted to the DNA-bound complexes of
RTP and BlaI with RMSD values of 2.9 A˚ (for 179 common Ca
atoms) and 3.4 A˚ (for 155 common Ca atoms). Overall, the dimers
of bcPadR1 and bcPadR2 are highly similar to RTP and BlaI, but
there are small differences in the relative dispositions of the dimer-
related subunits which affect the relative orientations of the a3
helices. Since DNA-binding by transcription factors is often
associated with specific conformational changes in both protein
and DNA, the superpositions cannot be used to accurately predict
the details of the DNA binding mechanism of bcPadR1 and
bcPadR2. However, analysis of the models in combination with a
structure-based sequence alignment of bcPadR1, bcPadR2, RTP
and BlaI (Figure 5) leads to a few interesting observations. First,
like in RTP and BlaI, the complementary surfaces in bcPadR1 and
bcPadR2 that form the putative DNA binding sites are highly
Figure 5. Modeling of the DNA-bound bcPadR complexes. (A) Superposition of the bcPadR1 (light-green) and bcPadR2 (red) dimers onto DNA-
bound RTP (orange, PDB code 1F4K). (B) Superposition of the bcPadR1 (light-green) and bcPadR2 (red) dimers onto DNA-bound BlaI (cyan, PDB code
1XSD). Below the superpositions are structure-based sequence alignments including secondary structures. Residues of RTP and BlaI which participate
in DNA binding are indicated with small spheres using the following color scheme: green, interacting with the phosphate backbone; blue, interacting
with the base moiety and yellow, interacting with the ribose backbone).
doi:10.1371/journal.pone.0048015.g005
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positively charged, due to the presence of various lysine and
arginine residues. A number of these lysine and arginine residues
from part of the previously described conserved sequence motifs in
the PadR-s2 proteins, in particular those located in helix a3 and
the b-wing, strongly implying a direct role in DNA binding.
Furthermore, the conserved YGYE motif in bcPadR1 and
bcPadR2, which is located at the N-terminal end of helix a2, is
partly preserved in RTP (residues 33–36 with sequence YGLK). In
RTP, the side chain of Tyr33, together with the backbone amides
of Gly34 and Leu35, forms hydrogen bonds with the phosphate-
backbone of the DNA. As these interactions are crucial for the
strong DNA binding affinity of RTP [36], it is likely that the
conserved residues in bcPadR1 and bcPadR2 have a similar DNA
binding role. This is corroborated by the observation of a bound
sulfate anion in the bcPadR1 structure, which forms interactions
with the highly conserved residues Gly25, Tyr26, Glu42 Arg71,
and Lys72, likely mimicking the interactions with a phosphate
moiety of the DNA backbone (Figure 6). Finally, the a3 helices of
the bcPadR proteins show a limited number of conserved residues
relative to the equivalent helices in RTP and BlaI. Interestingly,
two residues of the conserved EGTLYPxLxRLE motif are
identical to sequence-specific DNA binding residues in RTP or
BlaI, i.e., Tyr46 and Arg51, strongly suggesting that these residues
in helix a3 of the bcPadR proteins have a similar DNA binding
role. However, the limited overall sequence conservation of the a3
helices is also indicative of the differences that must exist between
the specific cognate operator sequences of these DNA-binding
proteins.
Discussion
In this study, we have determined the crystal structures of
bcPadR1 and bcPadR2, which are the products of gene loci
BC4206 and BCE3449 of B. cereus strains ATCC 14579 and
ATCC 10987, respectively. Functional data point toward the
hypothesis that bcPadR1 autoregulates the transcription of its own
gene, as bcPadR1 binds to the promoter region of gene BC4206
and overexpression of BC4206 gene results in increased sensitivity
against AS-48. The structures of bcPadR1 and bcPadR2 are similar
to LmrR, containing a conserved N-terminal wHTH DNA
binding domain and a C-terminal helix involved in dimerization.
The conserved structures and sequence relationships confirm that
all three proteins belong to the same subfamily of small PadR
proteins (subfamily 2 according to Huillet et al. [4], which we
abbreviated as PadR-s2.) The identification of conserved sequence
motifs in the wHTH domains, in particular in the a3 DNA
recognition helix, further suggests that the PadR-s2 proteins share
a common cognate DNA operator sequence. Operator sites of
LmrR in the lmrR and lmrCD promoter regions have been
identified previously [5,12], and were shown to contain an
ATGT/ACAT inverted sequence motif, separated by a short
spacer of about 8–10 nucleotides. The inverted repeat is identical
to the conserved DNA sequence motif revealed for members of the
other subfamily of PadR proteins (PadR-s1 family) [1,37]. Indeed,
similar sequence motifs, although somewhat degenerate, are
present in the promoter of the BC4206–4207 operon [ATGT-
(N)10-ATAA, Figure 1B] and the putative promoter region
preceding BCE3449 [CTGT-(N)8-ATAT, data not shown].
Functional studies and footprinting analysis are required to fully
establish the identity of the target DNA operator sites and to
identify other possible target genes controlled by bcPadR1 and
bcPadR2.
Compared to related transcription factors of the MarR, SmtB/
ArsR and MecI/BlaI families, the bcPadR proteins show a
‘‘minimal’’ fold, lacking extra N- and C-terminal helices associated
with dimerization. In the non-PadR-like proteins the extra helices
often play a role in the mechanisms of transcriptional induction,
allowing modulation of DNA binding activities through direct
binding of a ligand. Also the structural features in LmrR that are
related with its role as a multi-drug induced transcription
regulator, i.e., a large central pore with two opposing tryptophan
residues for multi-drug binding, are notably absent in bcPadR1
and bcPadR2. These observations suggestthat the DNA binding
activities of bcPadR1 and bcPadR2 are not directly modulated by
ligands. In line with this hypothesis, in vitro DNA binding of
bcPadR1 was not altered by the presence of AS-48. This is not
surprising since AS-48 is known to target the cell membrane,
inducing membrane pore formation [14], and is unlikely to enter
the cytoplasm. Perhaps, the bcPadR proteins undergo a confor-
mational change, which opens the dimer interface, thereby
forming a ligand binding site. Alternatively, transcriptional
regulating by the bcPadR proteins may involve an indirect
induction mechanism with the participation of another protein.
Such a mechanism has been proposed for the phenolic acid stress
Figure 6. The bound sulfate anion in the bcPadR1 structure. (A)
Interactions between bcPadR1 residues and the sulfate ion. Also shown
is the DNA-bound RTP structure (PDB entry 1F4K) onto which the
bcPadR1 dimer was superimposed. The bcPadR1 residues and the
sulfate ion are shown in ball-and-stick representation and labeled, while
the DNA strand of the RTP-DNA complex is drawn using lines. (B)
Interactions between the RTP residues and the DNA phosphate
backbone adjacent to the sulfate anion in the superimposed bcPadR1
structure. The RTP residues and DNA strands are shown in ball-and-stick
representation and labeled, while the bcPadR1 residues and sulfate are
drawn using lines.
doi:10.1371/journal.pone.0048015.g006
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response in L. plantarum, which is regulated by the founding
member of the PadR-like transcription factors and involves a
protein belonging to the universal stress protein family [38,39].
Examining such possibilities for the mechanism of action of the
bcPadR proteins has to await experimental data characterizing
their regulatory functions and identifying the target genes which
they control.
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